GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuGen Medical Devices Inc (TSXV:NGMD) » Definitions » Cash, Cash Equivalents, Marketable Securities

NuGen Medical Devices (TSXV:NGMD) Cash, Cash Equivalents, Marketable Securities : C$0.46 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NuGen Medical Devices Cash, Cash Equivalents, Marketable Securities?

NuGen Medical Devices's quarterly cash, cash equivalents, marketable securities increased from Mar. 2023 (C$0.45 Mil) to Sep. 2023 (C$1.67 Mil) but then stayed the same from Sep. 2023 (C$1.67 Mil) to Dec. 2023 (C$0.46 Mil).

NuGen Medical Devices's annual cash, cash equivalents, marketable securities declined from Dec. 2021 (C$1.75 Mil) to Dec. 2022 (C$0.13 Mil) but then increased from Dec. 2022 (C$0.13 Mil) to Dec. 2023 (C$0.46 Mil).


NuGen Medical Devices Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for NuGen Medical Devices's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuGen Medical Devices Cash, Cash Equivalents, Marketable Securities Chart

NuGen Medical Devices Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash, Cash Equivalents, Marketable Securities
0.27 1.75 0.13 0.46

NuGen Medical Devices Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.13 0.45 1.67 0.46

NuGen Medical Devices Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


NuGen Medical Devices  (TSXV:NGMD) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


NuGen Medical Devices Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of NuGen Medical Devices's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


NuGen Medical Devices (TSXV:NGMD) Business Description

Industry
Traded in Other Exchanges
Address
18 King Street East, Suite 1400, Toronto, ON, CAN, M5C 1C4
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needless injector devices. Geographically the company generates revenue from Asia, Europe and others.
Executives
Richard Buzbuzian Director, Senior Officer

NuGen Medical Devices (TSXV:NGMD) Headlines

No Headlines